dylemmaz
Senior Member
- Messages
- 136
these things do take a lot of time. janet recently said that it’s such a difficult process because ron has to create entirely new technologies in order to go about his experiments in this field. but even she is telling him all the time to speed it up!First they announced with much pomp that they have found a big molecule blocking the mitochondria and that was the real deal. Nothing came out of it.
Second they talked about the nano needle and said this will solve the problem of ME in a jiffy and nothing came out of it.
Third they started talking about the metabolic trap and nothing came out of it.
Now abilify and nothing will come out of it. Why is that just because abilify works in Whitney it deserves a clinical trial and not the other anti psychotics which have worked for different patients like ziprasidone in my case, amisulpiride in @Hip I think and others which people have tried.
Maybe it is all part of the fund raising gimmick. They have listed 20 projects in the list of to do projects and none completed except for the preload failure (Thanks to David Systrom).
I am just fedup with all this and we dont have a good competing research organization to turn to. Polybio ? well maybe.
right now it seems ron has put the nano needle on hold while he uses funding for other things.
personally i think the metabolic trap developments have been impressive and encouraging. in his most recent update ron said it’s currently stalled because his robots that he will be using to test the fda approved drugs on the yeast are broken, and he is working on getting them repaired. but aside from that the testing on yeast should go by swiftly and we may find a drug by the end of the year that fixes the trap in yeast.
there are great things happening because of abilify. ron said in his last youtube update that he is doing a meta analysis on drugs similar to abilify that may have a better effect on dopamine. so i wouldn’t say he isn’t looking in to other antipsychotics because he most likely is!